Journal
Journal of the American Heart Association
Publication Date
1-2-2024
Volume
13
Issue
1
First Page
e032236
Document Type
Open Access Publication
DOI
10.1161/JAHA.123.032236
Rights and Permissions
Sanuade OA, Jacobson TA, Quintana A, Flowers FM, Abbasi H, Vu MH, Baldridge AS, Mejia J, Lazar D, Ciolino JD, Huffman MD, Kandula NR. Process Evaluation of a Double-Blind Randomized Controlled Trial to Assess the Efficacy and Safety of a Quadruple Ultra-Low-Dose Treatment for Hypertension Within a Federally Qualified Health Center Network (QUARTET USA). J Am Heart Assoc. 2024 Jan 2;13(1):e032236. doi: 10.1161/JAHA.123.032236. © 2023 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
Recommended Citation
Sanuade, Olutobi A; Jacobson, Tyler A; Quintana, Adriana; Flowers, Fallon M; Abbasi, Hiba; Vu, My H; Baldridge, Abigail S; Mejia, Jairo; Lazar, Danielle; Ciolino, Jody D; Huffman, Mark D; and Kandula, Namratha R, "Process evaluation of a double-blind randomized controlled trial to assess the efficacy and safety of a Quadruple Ultra-Low-Dose Treatment for Hypertension within a federally qualified health center network (QUARTET USA)." Journal of the American Heart Association. 13, 1. e032236 (2024).
https://digitalcommons.wustl.edu/oa_4/4187
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
